A Single-Dose Study of LY3471851 in Healthy Participants
Is a
Allocation Type
Randomized
0
Trial Collaborator
Health Conditions in Trial
Intervention Model
Parallel Assignment
0
Intervention Name
LY3471851
0
Interventional Trial Phase
Phase 1
0
Interventional Trial Purpose
Basic Science
0
Intervention Type
Drug
0
Last Updated
November 18, 2023
0
Masking Type
None (Open Label)
0
Primary Completion Date
July 6, 2022
0
Trial Recruitment Size
71
0
Trial Sponsor
Clinical Trial Start Date
August 16, 2021
0
Study Completion Date
July 6, 2022
0
Clinical Trial Study Type
Interventional
0
NCT Number
Official Name
A Phase 1, Randomized, Open-Label, Single-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Subcutaneous LY3471851 in Healthy Participants
0
Official Website
Find more entities like A Single-Dose Study of LY3471851 in Healthy Participants
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.